FTC sues main pharmacy benefit administrators about insulin charges The agency introduced action versus Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the list price of life-conserving insulin medications. Elevance lowers steerage on ‘unprecedented’ Medicaid worries Executives stated the elevated expenses pr... https://dave-s-hot-chicken-nutrit72726.elbloglibre.com/30595197/top-latest-five-healthcare-news-urban-news